Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameTaimei Tech
Stock Code02576
Company Full NameTo be extracted
Industry軟件服務
Principal Activities公司是中國醫藥及醫療器械研發和營銷領域最大的數字化解決方案供應商,為醫藥及醫療器械行業的產業鏈各方設計并提供專業的軟件及數字化服務。
Listing Date2024-10-08
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國浙江省嘉興市昌盛南路36號智慧產業創新園9號樓3樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.taimei.com/
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo data

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 13.00 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)To be confirmed
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionTo be confirmed
Total Global Offering SizeHK$ 167,564,800

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 200 HK$ 2,600
2 lots 400 HK$ 5,200
3 lots 600 HK$ 7,800
4 lots 800 HK$ 10,400
5 lots 1,000 HK$ 13,000
6 lots 1,200 HK$ 15,600
7 lots 1,400 HK$ 18,200
8 lots 1,600 HK$ 20,800
9 lots 1,800 HK$ 23,400
10 lots 2,000 HK$ 26,000
15 lots 3,000 HK$ 39,000
20 lots 4,000 HK$ 52,000
25 lots 5,000 HK$ 65,000
30 lots 6,000 HK$ 78,000
35 lots 7,000 HK$ 91,000
40 lots 8,000 HK$ 104,000
45 lots 9,000 HK$ 117,000
50 lots 10,000 HK$ 130,000
100 lots 20,000 HK$ 260,000
150 lots 30,000 HK$ 390,000
200 lots 40,000 HK$ 520,000
250 lots 50,000 HK$ 650,000
300 lots 60,000 HK$ 780,000
350 lots 70,000 HK$ 910,000
400 lots 80,000 HK$ 1,040,000
450 lots 90,000 HK$ 1,170,000
500 lots 100,000 HK$ 1,300,000
750 lots 150,000 HK$ 1,950,000
1,000 lots 200,000 HK$ 2,600,000
1,250 lots 250,000 HK$ 3,250,000
1,500 lots 300,000 HK$ 3,900,000
1,750 lots 350,000 HK$ 4,550,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
2,000 lots 400,000 HK$ 5,200,000
2,250 lots 450,000 HK$ 5,850,000
2,500 lots 500,000 HK$ 6,500,000
3,000 lots 600,000 HK$ 7,800,000
3,500 lots 700,000 HK$ 9,100,000
4,000 lots 800,000 HK$ 10,400,000
4,500 lots 900,000 HK$ 11,700,000
5,000 lots 1,000,000 HK$ 13,000,000
5,604 lots 1,120,800 HK$ 14,570,400

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway None
HK Market Cap ---
Est. Threshold ---
Analysis Result 无法确定入通路径

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 9.2
First Day OpenHK$ 11.24
First Day Change-29.23%
First Day Volume16319600.0
First Day Turnover171030000.0
Use of Proceeds
1、約35%或65.0百萬港元將用于優化并升級TrialOS平臺及PharmaOS平臺及其 各自的云端軟件及數字化服務; 2、約30%或約55.7百萬港元將用于提升核心技術及研發能力; 3、約10%或18.6百萬港元將用于強化銷售及營銷能力; 4、約15%或27.9百萬港元將用于選擇性地尋求認為將能擴充現有產品及服務品類、擴大客戶基礎及提升技術能力的戰略投資及收購; 5、約10%或18.6百萬港元將用作營運資金及一般企業用途。

Underwriting Syndicate

Joint Sponsors (2)
Morgan Stanley Asia Limited CE AAD291 中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
Morgan Stanley Asia Limited CE AAD291 中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (8)
Morgan Stanley Asia Limited CE AAD291 中国国际金融香港证券有限公司 CE AEN894 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 招银国际融资有限公司 CE AVM940 建银国际金融有限公司 CE AJO225 富途证券国际(香港)有限公司 CE AZT137 老虎证券(香港)环球有限公司 CE BMU940 VALUABLE CAPITAL LIMITED CE AUL711
Joint Lead Managers (8)
Morgan Stanley Asia Limited CE AAD291 中国国际金融香港证券有限公司 CE AEN894 HUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED CE AOK809 招银国际融资有限公司 CE AVM940 建银国际金融有限公司 CE AJO225 富途证券国际(香港)有限公司 CE AZT137 老虎证券(香港)环球有限公司 CE BMU940 VALUABLE CAPITAL LIMITED CE AUL711

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman趙璐—
Company Secretary倪曉梅,潘秉揚—
No director data available.

Major Shareholders

Major Shareholders & Holdings趙璐(16.60%),林芝騰訊投資管理有限公司(10.01%),經緯創騰(杭州)創業投資合伙企業(有限合伙)(9.00%)
About this page

This page shows Taimei Tech (02576) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect